Pulmonary Hypertension in Heart Failure Preserved Ejection Fraction: Prevalence, Pathophysiology, and Clinical Perspectives

Circulation. Heart failure - United States
doi 10.1161/circheartfailure.113.000823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Sex and Heart Failure With Preserved Ejection Fraction: From Pathophysiology to Clinical Studies

Journal of Clinical Medicine
2019English

Diffuse Right Ventricular Fibrosis in Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Pulmonary Hypertension Is Related to Peripheral Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Heart Failure With Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment

Open Access Macedonian Journal of Medical Sciences
Medicine
2015English

Treating Heart Failure With Preserved Ejection Fraction: Learning From Pulmonary Fibrosis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Acute Hemodynamic Effects of Inhaled Iloprost

Pulmonary Circulation
PulmonaryRespiratory Medicine
2015English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy